Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Severe combined immunodeficiency
- Diseases associated with IL-7R polymorphisms
- Thymic defect in IL-7R-/- mice
- Gene therapy of SCID
- Gene therapy and cancer risk
- Gamma-c cytokine receptors
- IL7 receptor knockout
- IL7 ligand knockout
- Effect of IL-7 survival of pro-T subsets
- Bcl-2 family of anti and pro-apoptotic proteins
- Trophic factor & mitochondrial damage
- Bcl-2 promotes D1 cell survival
- Bax deficiency restores T cell development
- The effect of IL-7 withdrawal
- IL-7R mutants from human T-ALL
- Mutant hIL-7R and ligand-independent signaling
- D1 cells with mutant hIL-7R induce tumors in vivo
- Mutant IL-7R converts D1 to tumor-forming cells
- Hematopoietic neoplasm in multiple organs
- hIL-7Ralpha mutants promote dimerization
- Mutant IL-7Ralpha model
- Exon 6 of IL-7Ralpha (1)
- Exon 6 of IL-7Ralpha (2)
- Lymphocyte homeostasis
- Homeostatic correction
- Resource limitation example (1)
- Resource limitation example (2)
- Resource limitation example (3)
- Resource limitation example (4)
- Resource limitation example (5)
- Resource limitation example (6)
- IL-7 and nave CD8 homeostasis
- Classical proliferation pathway model
- IL-7/IL-3 proliferation pathway model (1)
- IL-7/IL-3 proliferation pathway model (2)
- IL-7/IL-3 proliferation pathway illustration
- Thymic cells expressing knock-in IL-7-CFP
- Class II MHC expression on thymic epithelium
- Class II MHC expression on skin dendritic cells
- Developing thymocides grow in a matrix
- Matrix nature
- Thymic epithelial cell matrix
- Looking down through the matrix
- In the embryonic thymus
- IL-7-CFP knock-in
- IL-7 in the bone marrow
- rhIL-7 increases in vivo TCR repertoire diversity
- IL-7 drives T cell-cycle entry & expansion in HIV-1
- Progressive multifocal leukoencephalopathy
- IL-7 improves survival in sepsis
- Treatment with IL-7 inhibitors
- Acknowledgments
- Producing cytokines painting
Topics Covered
- IL-7 in T cell development
- IL-7R in leukemia
- IL-7 in T cell homeostasis
- IL-7-expressing cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Durum, S. (2012, December 18). Interleukin-7 and T cells [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/KBVS6246.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Scott Durum has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.